MedTrace Logo

Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery

NCT03085394 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2023-04-19

No results posted yet for this study

Summary

Prophylactic use of tranexamic acid to reduce intra and postoperative bleeding in primary sleeve gastrectomy procedures will be studied.

Conditions

  • Intra-Operative Injury - Other
  • Post Operative Hemorrhage
  • Tranexamic Acid

Interventions

DRUG

tranexamic acid

Preoperative intravenous administration of 2 grams tranexamic acid in 10 ml saline

DRUG

Placebo

Preoperative intravenous administration of 10 ml saline

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2022-11-21
Completion
2022-11-21

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03085394 on ClinicalTrials.gov